THE TREATMENT OF CORONARY-ARTERY DISEASE IN THE ELDERLY

被引:7
作者
BACKES, RJ [1 ]
GERSH, BJ [1 ]
机构
[1] MAYO CLIN & MAYO FDN,DIV CARDIOVASC DIS & INTERNAL MED,ROCHESTER,MN 55905
关键词
ELDERLY; CORONARY ARTERY DISEASE; BALLOON DILATATION; BYPASS GRAFTING;
D O I
10.1007/BF03029769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changing population demographics dictate that in the next decade physicians will be increasingly faced with treating coronary artery disease in the elderly. Despite this, there is a paucity of data to guide management decisions in this population. Currently, it appears that "low-risk" or mild coronary artery disease can be treated medically so long as appropriate adjustments are made for aging changes in renal function, hepatic metabolism, noncompliance, multisystem disease, etc. Unfortunately, most elderly patients have "high-risk" or severe coronary artery disease. Balloon dilatation can yield excellent results in certain highly selected "high-risk" patients, but its role in the frequently encountered multivessel disease patient is unclear until current studies are completed. Coronary bypass grafting in selected patients clearly prolongs survival, but careful patient selection and meticulous preoperative and postoperative is required. Finally, the importance of issues such as quality of life, function independence, and cost must be addressed in more detail if physicians are to make rational decisions in treating this expanding population.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 47 条
[1]  
Wenger N.K., Marcus F.I., O'Rourke R.A., Cardiovascular disease in the elderly, Journal of the American College of Cardiology, 10, pp. 80A-87A, (1987)
[2]  
Seigal J.S., Recent and prospective demographic trends for the elderly population and some implications for health care, Second Conference on Epidemiology of Aging, (1980)
[3]  
Wei J.Y., Gersh B.J., Heart disease in the elderly, Curr Prob Cardiol, 12, pp. 50-65, (1987)
[4]  
Kashyap M.L., Cardiovascular disease in the elderly: Current considerations, The American Journal of Cardiology, 63, pp. 3H-4H, (1989)
[5]  
Stason W.B., Sanders C.A., Smith H.C., Cardiovascular care of the elderly: Economic considerations, Journal of the American College of Cardiology, 10, pp. 18A-21A, (1987)
[6]  
Herd J.A., Medical therapy in the elderly, J Am Coll Cardiol, 10, pp. 29A-33A, (1987)
[7]  
Triggs E.J., Nation R.L., Pharmacokinetics in the aged. A review, J Pharmacokin Biopharm, 3, pp. 387-418, (1975)
[8]  
Vestal R.E., Drug use in the elderly: A review of problems and special considerations, Drugs, 16, pp. 358-382, (1978)
[9]  
Crooks J., O'Malley K., Stevenson I.H., Pharmacokinetics in the elderly, Clin Pharmacokin, 1, pp. 280-296, (1976)
[10]  
Greenblatt D.J., Sellers E.M., Shader R.L., Drug disposition in all ages, N Engl J Med, 306, pp. 1081-1088, (1982)